EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Topical Versus Systemic Tranexamic Acid to Reduce Blood Loss After Total Knee and Total Hip Arthroplasty

Maude Boucher iD, Juliette Tremblay iD, Théo Pelet iD, Julien Dartus iD, Etienne L Belzile, Stéphane Pelet iD

Journal of Bone and Joint Surgery · 15.10.2025 · 107 (20) · 2300-2309

DOI: 10.2106/jbjs.24.01511 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 05.08.2025. Verfasst von Maude Boucher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Tranexamic Acid, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Antifibrinolytic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 121 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tranexamic acid (TXA) has been shown to reduce blood loss during total knee arthroplasty (TKA) and total hip arthroplasty (THA), but the most effective administration method has yet to be determined. This systematic review and meta-analysis aimed to compare topical and systemic TXA administration to reduce operative blood loss.

Methods

MEDLINE, Embase, and Cochrane CENTRAL were screened for randomized controlled trials comparing topical and systemic TXA for patients who underwent elective TKA and THA. The primary outcome was the total volume of operative blood loss, and the secondary outcomes were postoperative transfusion requirements, hemoglobin drop, hospital length of stay, and the frequencies of the main adverse events (infections and thromboembolic events). Data pooling was performed using RStudio. Subgroup analyses compared outcomes between TKA and THA.

Results

Fifty-nine randomized controlled trials with a total of 6,791 patients were included in this review. Data analysis showed no significant difference between topical and systemic TXA application in terms of total blood loss (Hedges g = 0.11; 95% confidence interval [CI], −0.04 to 0.26; I 2 = 82.4%). There was also no significant difference between the 2 groups in hemoglobin drop, hospital length of stay, and transfusion requirements. Subgroup analysis showed that patients undergoing TKA who received topical TXA had a significant reduction in total blood loss (g = 0.19; 95% CI, 0.00 to 0.38; I 2 = 85%; p = 0.046) compared with those who received systemic TXA.

Conclusions

Topical and systemic TXA were equally effective in reducing blood loss in the analysis in which THA and TKA were combined. However, in TKA, topical application significantly reduced blood loss compared with systemic administration, while the reverse was true in THA. Further research is still necessary to find the optimal TXA dosage and administration route. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidArthroplasty, Replacement, HipArthroplasty, Replacement, KneeAntifibrinolytic AgentsBlood Loss, SurgicalPostoperative HemorrhageHumansAdministration, TopicalBlood TransfusionRandomized Controlled Trials as Topic

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.
  • Département Universitaire de Chirurgie Orthopédique et Traumatologique, Hôpital Roger Salengro, CHU de Lille, Lille, France.
  • Division of Orthopedic Surgery, Department of Surgery, CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
  • Axe Médecine Régénératrice, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, Quebec, Canada.

ORCID-Profile: Maude Boucher, Juliette Tremblay, Théo Pelet, Julien Dartus, Stéphane Pelet

Zitieren

APA

Boucher, M., Tremblay, J., Pelet, T., Dartus, J., Belzile, E. L., & Pelet, S. (2025). Topical Versus Systemic Tranexamic Acid to Reduce Blood Loss After Total Knee and Total Hip Arthroplasty. Journal of Bone and Joint Surgery, 107(20), 2300-2309. https://doi.org/10.2106/jbjs.24.01511

Vancouver

Boucher M, Tremblay J, Pelet T, Dartus J, Belzile EL, Pelet S. Topical Versus Systemic Tranexamic Acid to Reduce Blood Loss After Total Knee and Total Hip Arthroplasty. Journal of Bone and Joint Surgery. 2025;107(20):2300-2309. doi:10.2106/jbjs.24.01511

BibTeX
@article{Boucher2025,
  author = {Boucher, Maude and Tremblay, Juliette and Pelet, Théo and Dartus, Julien and Belzile, Etienne L and Pelet, Stéphane},
  title = {Topical Versus Systemic Tranexamic Acid to Reduce Blood Loss After Total Knee and Total Hip Arthroplasty},
  journal = {Journal of Bone and Joint Surgery},
  year = {2025},
  volume = {107},
  number = {20},
  pages = {2300--2309},
  doi = {10.2106/jbjs.24.01511}
}
Kostenlos starten →